Lixisenatide acetate

Modify Date: 2024-02-07 13:34:19

Lixisenatide acetate structure	Common Name	Lixisenatide acetate
	CAS Number	1997361-87-1	Molecular Weight	N/A
	Density	N/A	Boiling Point	N/A
	Molecular Formula	C₂₁₅H₃₄₇N₆₁O₆₅S_.xC₂H₄O₂	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of Lixisenatide acetate

Lixisenatide acetate is a glucagon-like peptide-1 (GLP-1) receptor agonist that can be used in the treatment of type 2 diabetes mellitus (T2DM).

Name	Lixisenatide acetate

Description	Lixisenatide acetate is a glucagon-like peptide-1 (GLP-1) receptor agonist that can be used in the treatment of type 2 diabetes mellitus (T2DM).
Target	GLP-1 receptor[1][2].
References	[1]. Ahrén B et al. Postprandial Glucagon Reductions Correlate to Reductions in Postprandial Glucose and Glycated Hemoglobin with Lixisenatide Treatment in Type 2 Diabetes Mellitus: A Post Hoc Analysis. Diabetes Ther. 2016 Jun 18. [2]. Lorenz M, et al. Effects of lixisenatide once daily on gastric emptying in type 2 diabetes--relationship to postprandial glycemia. Regul Pept. 2013 Aug 10;185:1-8.

Description

Lixisenatide acetate is a glucagon-like peptide-1 (GLP-1) receptor agonist that can be used in the treatment of type 2 diabetes mellitus (T2DM).

Target

GLP-1 receptor[1][2].

References

Molecular Formula	C₂₁₅H₃₄₇N₆₁O₆₅S_.xC₂H₄O₂

Get all suppliers and price by the below link: